BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 27717198)

  • 21. The Role of Molecular Testing for the Indeterminate Thyroid FNA.
    Rossi ED; Pantanowitz L; Faquin WC
    Genes (Basel); 2019 Sep; 10(10):. PubMed ID: 31547603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analytical validity of a microRNA-based assay for diagnosing indeterminate thyroid FNA smears from routinely prepared cytology slides.
    Benjamin H; Schnitzer-Perlman T; Shtabsky A; VandenBussche CJ; Ali SZ; Kolar Z; Pagni F; ; Bar D; Meiri E
    Cancer Cytopathol; 2016 Oct; 124(10):711-721. PubMed ID: 27223344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.
    Nikiforov YE; Steward DL; Robinson-Smith TM; Haugen BR; Klopper JP; Zhu Z; Fagin JA; Falciglia M; Weber K; Nikiforova MN
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2092-8. PubMed ID: 19318445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Highly Sensitive and Specific Molecular Test for Mutations in the Diagnosis of Thyroid Nodules: A Prospective Study of
    Cho YY; Park SY; Shin JH; Oh YL; Choe JH; Kim JH; Kim JS; Yim HS; Kim YL; Ki CS; Kim TH; Chung JH; Kim SW
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates.
    Marchetti I; Lessi F; Mazzanti CM; Bertacca G; Elisei R; Coscio GD; Pinchera A; Bevilacqua G
    Thyroid; 2009 Aug; 19(8):837-42. PubMed ID: 19534623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FNA smears as a potential source of DNA for targeted next-generation sequencing of lung adenocarcinomas.
    Treece AL; Montgomery ND; Patel NM; Civalier CJ; Dodd LG; Gulley ML; Booker JK; Weck KE
    Cancer Cytopathol; 2016 Jun; 124(6):406-14. PubMed ID: 26882436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic value and lymph node metastasis prediction of a custom‑made panel (thyroline) in thyroid cancer.
    Ke Z; Liu Y; Zhang Y; Li J; Kuang M; Peng S; Liang J; Yu S; Su L; Chen L; Sun C; Li B; Cao J; Lv W; Xiao H
    Oncol Rep; 2018 Aug; 40(2):659-668. PubMed ID: 29901149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preanalytic variables in quality and quantity of nucleic acids extracted from FNA specimens of thyroid gland nodules collected in CytoLyt: Cellularity and storage time.
    Heymann JJ; Yoxtheimer LM; Park HJ; Fernandez EM; Facey KE; Alperstein SA; Tran HV; Baek I; Scognamiglio T; Rennert H; Siddiqui MT; Song W
    Cancer Cytopathol; 2020 Sep; 128(9):656-672. PubMed ID: 32267620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the Real-Q BRAF V600E Detection Assay in Fine-Needle Aspiration Samples of Thyroid Nodules.
    Park KS; Oh YL; Ki CS; Kim JW
    J Mol Diagn; 2015 Jul; 17(4):431-7. PubMed ID: 25937618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analytical validation of a novel targeted next-generation sequencing assay for mutation detection in thyroid nodule aspirates and tissue.
    Verrienti A; Pecce V; Abballe L; Ramundo V; Falcone R; Inanloo Nigi Jak F; Brunelli C; Fadda G; Bosco D; Ascoli V; Carletti R; Di Gioia C; Grani G; Sponziello M
    Endocrine; 2020 Aug; 69(2):451-455. PubMed ID: 32506194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The molecular diagnosis and management of thyroid neoplasms.
    Theoharis C; Roman S; Sosa JA
    Curr Opin Oncol; 2012 Jan; 24(1):35-41. PubMed ID: 22123232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology.
    Cantara S; Capezzone M; Marchisotta S; Capuano S; Busonero G; Toti P; Di Santo A; Caruso G; Carli AF; Brilli L; Montanaro A; Pacini F
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1365-9. PubMed ID: 20130073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preoperative molecular testing on fine-needle aspiration in precision management of thyroid cancer].
    Song YT; Zhang B
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jan; 54(1):58-61. PubMed ID: 30704174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative analysis of diagnostic performance, feasibility and cost of different test-methods for thyroid nodules with indeterminate cytology.
    Sciacchitano S; Lavra L; Ulivieri A; Magi F; De Francesco GP; Bellotti C; Salehi LB; Trovato M; Drago C; Bartolazzi A
    Oncotarget; 2017 Jul; 8(30):49421-49442. PubMed ID: 28472764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular diagnostics and predictors in thyroid cancer.
    Nikiforova MN; Nikiforov YE
    Thyroid; 2009 Dec; 19(12):1351-61. PubMed ID: 19895341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The diagnostic application of RNA sequencing in patients with thyroid cancer: an analysis of 851 variants and 133 fusions in 524 genes.
    Pagan M; Kloos RT; Lin CF; Travers KJ; Matsuzaki H; Tom EY; Kim SY; Wong MG; Stewart AC; Huang J; Walsh PS; Monroe RJ; Kennedy GC
    BMC Bioinformatics; 2016 Jan; 17 Suppl 1(Suppl 1):6. PubMed ID: 26818556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules.
    Kim SK; Kim DL; Han HS; Kim WS; Kim SJ; Moon WJ; Oh SY; Hwang TS
    Diagn Mol Pathol; 2008 Jun; 17(2):118-25. PubMed ID: 18382358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of different methodologies on the detection of point mutations in routine air-dried fine needle aspiration (FNA) smears.
    Rehfeld C; Münz S; Krogdahl A; Jensen EM; Siebolts U; Ferraz C; Bösenberg E; Hegedüs L; Paschke R; Eszlinger M
    Horm Metab Res; 2013 Jul; 45(7):513-7. PubMed ID: 23508716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrating Molecular Testing in the Diagnosis and Management of Children with Thyroid Lesions.
    Ballester LY; Sarabia SF; Sayeed H; Patel N; Baalwa J; Athanassaki I; Hernandez JA; Fang E; Quintanilla NM; Roy A; López-Terrada DH
    Pediatr Dev Pathol; 2016; 19(2):94-100. PubMed ID: 26366474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant risk stratification of thyroid FNA specimens with indeterminate cytology based on molecular testing.
    Paskaš S; Janković J; Živaljević V; Tatić S; Božić V; Nikolić A; Radojković D; Savin S; Cvejić D
    Cancer Cytopathol; 2015 Aug; 123(8):471-9. PubMed ID: 25924719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.